RSV Vaccine Data Show Reduced Cardio-Respiratory Risks
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...
Paris, France | December 24, 2025 — Sanofi announced that it has entered into a definitive agreement to acquire...
